Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incremental Diagnostic Value of CT Fractional Flow Reserve Using Subtraction Method in Patients with Severe Calcification: A Pilot Study.
Kamo Y, Fujimoto S, Nozaki YO, Aoshima C, Kawaguchi YO, Dohi T, Kudo A, Takahashi D, Takamura K, Hiki M, Okai I, Okazaki S, Tomizawa N, Kumamaru KK, Aoki S, Minamino T. Kamo Y, et al. Among authors: okazaki s. J Clin Med. 2021 Sep 26;10(19):4398. doi: 10.3390/jcm10194398. J Clin Med. 2021. PMID: 34640414 Free PMC article.
Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study.
Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Yanagisawa N, Tamura H, Kojima T, Yokoyama K, Kurata T, Daida H. Dohi T, et al. Among authors: okazaki s. Atherosclerosis. 2010 Jun;210(2):497-502. doi: 10.1016/j.atherosclerosis.2009.12.001. Epub 2009 Dec 4. Atherosclerosis. 2010. PMID: 20036363 Clinical Trial.
Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting.
Miyazaki T, Shimada K, Miyauchi K, Kume A, Tanimoto K, Kiyanagi T, Sumiyoshi K, Hiki M, Mokuno H, Okazaki S, Sato H, Kurata T, Daida H. Miyazaki T, et al. Among authors: okazaki s. Lipids Health Dis. 2010 Oct 25;9:122. doi: 10.1186/1476-511X-9-122. Lipids Health Dis. 2010. PMID: 20973966 Free PMC article. Clinical Trial.
Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.
Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Ohkawa R, Nakamura K, Yanagisawa N, Tsuboi S, Ogita M, Yokoyama K, Kurata T, Yatomi Y, Daida H. Dohi T, et al. Among authors: okazaki s. Atherosclerosis. 2011 Dec;219(2):907-12. doi: 10.1016/j.atherosclerosis.2011.09.019. Epub 2011 Sep 17. Atherosclerosis. 2011. PMID: 22024276 Clinical Trial.
Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
Ogita M, Miyauchi K, Miyazaki T, Naito R, Konishi H, Tsuboi S, Dohi T, Kasai T, Yokoyama T, Okazaki S, Kurata T, Daida H. Ogita M, et al. Among authors: okazaki s. Heart Vessels. 2014 Jan;29(1):35-41. doi: 10.1007/s00380-013-0330-5. Epub 2013 Mar 21. Heart Vessels. 2014. PMID: 23516028
1,272 results